Related Experiment Video
Updated: Feb 11, 2026

Combining Multiplex Fluorescence In Situ Hybridization with Fluorescent Immunohistochemistry on Fresh Frozen or Fixed Mouse Brain Sections
Published on: June 25, 2021
Azilsartan and Chlorthalidone-new Powerful Fixed dose Antihypertensive Combination
Vasiliki Katsi1, Eleni Athanasiadi1, Costas Tsioufis1
11st Cardiology Department, Athens Medical School, University of Athens, "Hippokration" Hospital, Athens, Greece.
Insights
Azilsartan combined with chlorthalidone offers a superior antihypertensive effect compared to individual drugs or other common treatments. This combination is crucial for managing high blood pressure and reducing cardiovascular risks.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Arterial hypertension affects one-third of US adults, with only 54% controlled, costing $46 billion annually.
- High blood pressure significantly increases the risk of stroke and myocardial infarction worldwide.
- Novel therapeutic strategies for hypertension management are urgently needed.
Purpose of the Study:
- To evaluate the efficacy and safety of the azilsartan-chlorthalidone combination.
- To compare this combination against other widely used antihypertensive options.
- To review the latest findings on the clinical utility and adverse events of this combination therapy.
Main Methods:
- Review of recent clinical trials and scientific literature.
- Comparative analysis of azilsartan and chlorthalidone efficacy versus established antihypertensives.
- Assessment of safety profiles and adverse event data for the combination therapy.
Main Results:
- Both azilsartan and chlorthalidone demonstrate superior antihypertensive effects individually compared to certain alternatives.
- The combination of azilsartan and chlorthalidone exhibits enhanced efficacy in blood pressure reduction.
- Evidence suggests a favorable safety profile for the combination therapy.
Conclusions:
- The azilsartan-chlorthalidone combination represents a significant advancement in hypertension treatment.
- This combination offers a potent and potentially safer option for managing arterial hypertension.
- Further clinical research may solidify its role as a first-line or adjunctive therapy.
Abstract:
Arterial hypertension is a disease that still affects a major part of the population worldwide, and leads to fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. From the CDC statistical analysis, as regarding to United States, 1 of every 3 adults has high blood pressure, and οnly about half (54%) of them have it under control. Furthermore, all that leads to a nation cost about $46 billion each year. Efforts to find new ways to regulate arterial hypertension are therefore imperative. In our days, a lot of references have been made to the use of a new therapeutic combination, that of azilsartan - an innovative ARB, in combination with chlorthalidone. Ιn fact, it is a combination now prescribed in a number of countries. A significant number of trials shows both azilsartan vs popular antihypertensive drugs, as well as chlorthalidone vs chlorothiazide, to present a better antihypertensive effect. This effect is even greater when the two substances are combined. In this article, we will try to present the latest findings concerning the efficacy, safety and clinical utility of this combination, as well as its adverse events, in comparison with other widely used therapeutic options.
Related Concept Videos
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Action of Diuretics
Power
Fixed Action Patterns
Dose Size and Dosing Frequency: Determination Methods

